個別化がん治療の世界市場レポート 2025年

個別化がん治療の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR10.7％で3,030億1,000万米ドルに成長します。予測期間の成長は、標的治療の拡大、治療計画のためのAIと機械学習の進歩、がん研究への投資の増加、精密医療への需要の高まり、個別化治療のための新たなバイオマーカーの開発に起因すると考えられます。予測期間における主要動向としては、併用療法の増加、デジタルヘルスツールの統合の増加、リキッドバイオプシー技術の採用拡大、免疫療法の選択肢の拡大、患者中心のケアモデルへの注力の強化などが挙げられます。

がんの有病率の上昇は、今後数年間における個別化がん治療市場の成長を促進すると予想されます。このようながん患者の増加は、平均寿命が延び、がんが多発する年齢に達する人が増えたことに加え、タバコの使用、飲酒、肥満などの危険因子にさらされる機会が増えたことが主要原因です。個別化されたがん治療は、さまざまながん種や病期を管理するための的を絞った効果的な治療法を提供し、オーダーメイドの治療計画を通じて患者の転帰を改善することを目的とした精密医療への投資と技術革新を刺激しています。例えば、スイスに本部を置く世界保健機関（WHO）は2024年2月、世界のがん罹患率は大幅に上昇し、新たながん罹患者は2022年の2,000万人から77％増加し、2050年には3,500万人を超えると予測しています。このように、がんの有病率の増加が個別化がん治療市場を推進しています。

個別化がん治療セグメントの企業は、免疫療法に対する患者の反応を予測し、個別化治療戦略を強化するために、人工知能（AI）対応のマルチモーダル免疫プロファイルアルゴリズム検査などの革新的ソリューションの開発を優先しています。これらのAI対応検査は、ゲノム、トランスクリプトーム、臨床バイオマーカーなど様々なデータを分析して患者の免疫プロファイルを評価し、免疫療法に対する反応を予測することで、患者の層別化を支援し、個別化がん治療の指針となります。例えば、米国を拠点とする医療技術企業Tempus AI, Inc.は2024年7月、AIを活用したマルチモーダル免疫プロファイルアルゴリズム検査（IPS）を発表し、免疫療法診断セグメントに参入しました。この検査は研究用（RUO）のみ利用可能で、免疫療法に関連するバイオマーカーを評価し、免疫療法に対する患者の反応を予測するスコアを生成することで、個別化がん治療をサポートします。このようなAI主導の診断により、腫瘍学における患者の層別化と治療選択が強化されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の個別化がん治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の個別化がん治療市場：成長率分析
• 世界の個別化がん治療市場の実績：規模と成長、2019～2024年
• 世界の個別化がん治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の個別化がん治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の個別化がん治療市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 標的療法
• 免疫療法
• ホルモン療法
• 化学療法
• 放射線治療
• その他の治療タイプ
• 世界の個別化がん治療市場：診断技術別、実績と予測、2019～2024年、2024～2029年、2034年
• ゲノム配列分析
• 液体生検
• 免疫組織化学
• in situーハイブリダイゼーション
• バイオマーカー検査
• その他の診断技術
• 世界の個別化がん治療市場：がんタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 乳がん
• 肺がん
• 大腸がん
• 前立腺がん
• 黒色腫
• その他のがんタイプ
• 世界の個別化がん治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院とクリニック
• 研究機関
• その他
• 世界の個別化がん治療市場、標的療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• モノクローナル抗体
• 低分子阻害剤
• 血管新生阻害剤
• シグナル伝達阻害剤
• 世界の個別化がん治療市場、免疫療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• チェックポイント阻害剤
• CAR T細胞療法
• がんワクチン
• 免疫療法のためのモノクローナル抗体
• 世界の個別化がん治療市場、ホルモン療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗エストロゲン
• アロマターゼ阻害剤
• プロゲスチン
• LHRHアゴニスト
• 世界の個別化がん治療市場、化学療法のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アルキル化剤
• 代謝拮抗剤
• アントラサイクリン
• タキサン
• 世界の個別化がん治療市場、放射線治療のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 外部放射線治療（EBRT）
• 近接放射線療法
• 放射免疫療法
• 定位放射線手術（SRS）
• 世界の個別化がん治療市場、その他の治療タイプのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 遺伝子治療
• 幹細胞移植
• 代謝療法
• ナノ医療

第7章 地域別・国別分析

• 世界の個別化がん治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の個別化がん治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 個別化がん治療市場：競合情勢
• 個別化がん治療市場：企業プロファイル
  • Pfizer Inc.
  • Johnson & Johnson
  • F. Hoffmann-La Roche
  • Merck & Co. Inc.
  • Bristol Myers Squibb Company

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific Inc.
• AstraZeneca Plc
• Novartis AG
• BioNTech SE
• Illumina Inc.
• Artera
• Exact Sciences Corporation
• Moffitt Cancer Center
• Myriad Genetics
• NeoGenomics Laboratories
• Guardant Health
• Caris Life Sciences
• Tempus AI Inc.
• Foundation Medicine
• Immatics

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 個別化がん治療市場、2029年：新たな機会を提供する国
• 個別化がん治療市場、2029年：新たな機会を提供するセグメント
• 個別化がん治療市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Personalized cancer treatment tailors therapies based on an individual's unique genetic profile and tumor characteristics, aiming for more effective and targeted interventions. This approach enhances treatment plans and improves patient outcomes by analyzing genetic mutations and biomarkers, in contrast to traditional one-size-fits-all methods.

The main types of personalized cancer treatment encompass targeted therapy, immunotherapy, hormone therapy, chemotherapy, radiation therapy, and others. Targeted therapy employs drugs or other substances to specifically identify and attack cancer cells while sparing normal cells. Various diagnostic techniques, such as genomic sequencing, liquid biopsy, immunohistochemistry, in situ hybridization, and biomarker testing, are utilized for different cancer types, including breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, and more. These treatments are administered by end-users, including hospitals, clinics, and research institutes, among others.

The personalized cancer treatment market research report is one of a series of new reports from the business research company that provides personalized cancer treatment market statistics, including personalized cancer treatment industry global market size, regional shares, competitors with an personalized cancer treatment market share, detailed personalized cancer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the personalized cancer treatment industry. This personalized cancer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The personalized cancer treatment market size has grown rapidly in recent years. It will grow from $181.55 billion in 2024 to $201.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to advancements in genomics and molecular biology, increasing prevalence of cancer, a rise in personalized medicine adoption, growing awareness about cancer treatment options, and improved cancer diagnostics and monitoring technologies.

The personalized cancer treatment market size is expected to see rapid growth in the next few years. It will grow to $303.01 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to the expansion of targeted therapies, advancements in AI and machine learning for treatment planning, increasing investment in cancer research, growing demand for precision medicine, and the development of new biomarkers for personalized treatments. Major trends in the forecast period include the rising use of combination therapies, increased integration of digital health tools, growth in the adoption of liquid biopsy techniques, expansion of immunotherapy options, and enhanced focus on patient-centric care models.

The rising prevalence of cancer is expected to drive growth in the personalized cancer treatment market in the coming years. This increase in cancer cases is largely due to rising life expectancy, leading to more individuals reaching ages where cancer is more common, as well as heightened exposure to risk factors such as tobacco use, alcohol consumption, and obesity. Personalized cancer treatments offer targeted and effective therapies for managing various types and stages of cancer, stimulating investment and innovation in precision medicine aimed at improving patient outcomes through tailored treatment plans. For example, the World Health Organization, a Switzerland-based UN agency focused on global health, projected in February 2024 that the global cancer burden will rise significantly, with new cancer cases expected to increase by 77%, reaching over 35 million by 2050, compared to 20 million in 2022. Thus, the growing prevalence of cancer is propelling the personalized cancer treatment market.

Companies in the personalized cancer treatment sector are prioritizing the development of innovative solutions, such as artificial intelligence (AI)-enabled multimodal immune profile algorithmic tests, to predict patient responses to immunotherapy and enhance personalized treatment strategies. These AI-enabled tests analyze various data types, including genomic, transcriptomic, and clinical biomarkers, to evaluate a patient's immune profile and forecast their response to immunotherapy, aiding in patient stratification and guiding personalized cancer treatments. For instance, in July 2024, Tempus AI, Inc., a US-based health technology firm, launched its AI-enabled multimodal immune profile algorithmic test (IPS), marking its entry into the immunotherapy diagnostics field. The test, which is available for research use only (RUO), evaluates a range of immunotherapy-related biomarkers to generate a score that helps predict patient responses to immunotherapy, thereby supporting personalized cancer treatment. These AI-driven diagnostics enhance patient stratification and treatment selection in oncology.

In December 2023, Pfizer Inc., a US-based pharmaceutical and biotechnology company, acquired Seagen Inc. for $43 billion. This acquisition aims to utilize Pfizer's advanced antibody-drug conjugate technology to bolster its capabilities in developing targeted cancer therapies. This strategic move is intended to accelerate Pfizer's growth in the oncology market, addressing the pressing need for more effective cancer treatments. Seagen Inc. is a US-based biotechnology firm that specializes in monoclonal antibody-based therapies for cancer treatment.

Major companies operating in the personalized cancer treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche, Merck & Co. Inc., Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca Plc, Novartis AG, BioNTech SE, Illumina Inc., Artera, Exact Sciences Corporation., Moffitt Cancer Center, Myriad Genetics, NeoGenomics Laboratories, Guardant Health, Caris Life Sciences, Tempus AI Inc., Foundation Medicine, Immatics, Fate Therapeutics, CureVac AG, TScan Therapeutics, CureMetrix, PDC*line Pharma

North America was the largest region in the personalized cancer treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized cancer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized cancer treatment market consists of revenues earned by entities by providing services such as genetic testing, biomarker analysis, personalized therapy formulation, and targeted drug delivery. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized cancer treatment market also includes sales of products including targeted therapy drugs, genomic profiling kits, and companion diagnostics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Cancer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized cancer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized cancer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized cancer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Targeted Therapy; Immunotherapy; Hormone Therapy; Chemotherapy; Radiation Therapy; Other Treatment Type
• 2) By Diagnostic Techniques: Genomic Sequencing; Liquid Biopsy; Immunohistochemistry; In Situ Hybridization; Biomarker Testing; Other Diagnostic Techniques
• 3) By Cancer Type: Breast Cancer; Lung Cancer; Colorectal Cancer; Prostate Cancer; Melanoma; Other Cancer Types
• 4) By End-Users: Hospitals And Clinics; Research Institutes; Other End Users
• Subsegments:
• 1) By Targeted Therapy: Monoclonal Antibodies; Small Molecule Inhibitors; Angiogenesis Inhibitors; Signal Transduction Inhibitors
• 2) By Immunotherapy: Checkpoint Inhibitors; CAR T-Cell Therapy; Cancer Vaccines; Monoclonal Antibodies For Immunotherapy
• 3) By Hormone Therapy: Anti-Estrogens; Aromatase Inhibitors; Progestins; LHRH Agonists
• 4) By Chemotherapy: Alkylating Agents; Antimetabolites; Anthracyclines; Taxanes
• 5) By Radiation Therapy: External Beam Radiation Therapy (EBRT); Brachytherapy; Radioimmunotherapy; Stereotactic Radiosurgery (SRS)
• 6) By Other Treatment Types: Gene Therapy; Stem Cell Transplantation; Metabolic Therapy; Nanomedicine
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche; Merck & Co. Inc.; Bristol Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Personalized Cancer Treatment Market Characteristics

3. Personalized Cancer Treatment Market Trends And Strategies

4. Personalized Cancer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Personalized Cancer Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Personalized Cancer Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Personalized Cancer Treatment Market Growth Rate Analysis
• 5.4. Global Personalized Cancer Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Personalized Cancer Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Personalized Cancer Treatment Total Addressable Market (TAM)

6. Personalized Cancer Treatment Market Segmentation

• 6.1. Global Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Targeted Therapy
• Immunotherapy
• Hormone Therapy
• Chemotherapy
• Radiation Therapy
• Other Treatment Type
• 6.2. Global Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genomic Sequencing
• Liquid Biopsy
• Immunohistochemistry
• In Situ Hybridization
• Biomarker Testing
• Other Diagnostic Techniques
• 6.3. Global Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Melanoma
• Other Cancer Types
• 6.4. Global Personalized Cancer Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research Institutes
• Other End Users
• 6.5. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Small Molecule Inhibitors
• Angiogenesis Inhibitors
• Signal Transduction Inhibitors
• 6.6. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Checkpoint Inhibitors
• CAR T-Cell Therapy
• Cancer Vaccines
• Monoclonal Antibodies For Immunotherapy
• 6.7. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Hormone Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Estrogens
• Aromatase Inhibitors
• Progestins
• LHRH Agonists
• 6.8. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alkylating Agents
• Antimetabolites
• Anthracyclines
• Taxanes
• 6.9. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Beam Radiation Therapy (EBRT)
• Brachytherapy
• Radioimmunotherapy
• Stereotactic Radiosurgery (SRS)
• 6.10. Global Personalized Cancer Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Stem Cell Transplantation
• Metabolic Therapy
• Nanomedicine

7. Personalized Cancer Treatment Market Regional And Country Analysis

• 7.1. Global Personalized Cancer Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Personalized Cancer Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Cancer Treatment Market

• 8.1. Asia-Pacific Personalized Cancer Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Cancer Treatment Market

• 9.1. China Personalized Cancer Treatment Market Overview
• 9.2. China Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Cancer Treatment Market

• 10.1. India Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Cancer Treatment Market

• 11.1. Japan Personalized Cancer Treatment Market Overview
• 11.2. Japan Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Cancer Treatment Market

• 12.1. Australia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Cancer Treatment Market

• 13.1. Indonesia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Cancer Treatment Market

• 14.1. South Korea Personalized Cancer Treatment Market Overview
• 14.2. South Korea Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Cancer Treatment Market

• 15.1. Western Europe Personalized Cancer Treatment Market Overview
• 15.2. Western Europe Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Cancer Treatment Market

• 16.1. UK Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Cancer Treatment Market

• 17.1. Germany Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Cancer Treatment Market

• 18.1. France Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Cancer Treatment Market

• 19.1. Italy Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Cancer Treatment Market

• 20.1. Spain Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Cancer Treatment Market

• 21.1. Eastern Europe Personalized Cancer Treatment Market Overview
• 21.2. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Cancer Treatment Market

• 22.1. Russia Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Cancer Treatment Market

• 23.1. North America Personalized Cancer Treatment Market Overview
• 23.2. North America Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Cancer Treatment Market

• 24.1. USA Personalized Cancer Treatment Market Overview
• 24.2. USA Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Cancer Treatment Market

• 25.1. Canada Personalized Cancer Treatment Market Overview
• 25.2. Canada Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Cancer Treatment Market

• 26.1. South America Personalized Cancer Treatment Market Overview
• 26.2. South America Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Cancer Treatment Market

• 27.1. Brazil Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Cancer Treatment Market

• 28.1. Middle East Personalized Cancer Treatment Market Overview
• 28.2. Middle East Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Cancer Treatment Market

• 29.1. Africa Personalized Cancer Treatment Market Overview
• 29.2. Africa Personalized Cancer Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Personalized Cancer Treatment Market, Segmentation By Diagnostic Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Personalized Cancer Treatment Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Cancer Treatment Market Competitive Landscape And Company Profiles

• 30.1. Personalized Cancer Treatment Market Competitive Landscape
• 30.2. Personalized Cancer Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Cancer Treatment Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. AstraZeneca Plc
• 31.3. Novartis AG
• 31.4. BioNTech SE
• 31.5. Illumina Inc.
• 31.6. Artera
• 31.7. Exact Sciences Corporation
• 31.8. Moffitt Cancer Center
• 31.9. Myriad Genetics
• 31.10. NeoGenomics Laboratories
• 31.11. Guardant Health
• 31.12. Caris Life Sciences
• 31.13. Tempus AI Inc.
• 31.14. Foundation Medicine
• 31.15. Immatics

32. Global Personalized Cancer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Cancer Treatment Market

34. Recent Developments In The Personalized Cancer Treatment Market

35. Personalized Cancer Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Personalized Cancer Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Personalized Cancer Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Personalized Cancer Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer